HomeAI · summaries
Storia in 2 fonti
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI Aayog
India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearly 65% of APIs and intermediates sourced from there. NITI Aayog's report highlights supply chain vulnerabilities and calls for moving up the value chain by fostering innovation and industry-academia collaboration. This strategic shift aims to boost high-value product development and capture a larger global market share.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI Aayog
India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearly 65% of APIs and intermediates sourced…
- ·
thehindubusinessline.com
India's pharma supply chain heavily dependent on Chinese imports: NITI Aayog
India's pharma supply chain relies 65% on Chinese imports, highlighting innovation gaps and calls for diversification, says NITI Aayog.